The Impact of Delay Between Biologic Prescription and Therapy Initiation on Clinical Outcomes in Inflammatory Bowel Disease Patients

Biologic therapy for the management of active inflammatory bowel disease (IBD) is expensive and the multi-step process prior to initiation of therapy can be associated with delay. The purpose of this study was to determine if such delay impacts clinical outcomes in IBD patients.

Source: Gastroenterology - June 28, 2019 Category: Gastroenterology Authors: Manasi Agrawal, Adam Tepler, Simon Hong, Rashmi Advani, Dana Lukin Tags: Abstract Source Type: research